Search
Search
Close this search box.

New Research Reveals Legal Cannabis Prices Nearing Parity with Illicit Market in Canada

Legal cannabis prices in Canada are catching up to their illegal counterparts for the first time, according to new research from Deloitte and Neobi

A new study, ‘Clearing the Smoke – Insights into Canada’s Illicit Cannabis Market’, examined available cannabis products on 624 legal adult-use stores, and 57 illegal unlicensed stores, seeking to compare the respective product catalogues and prices.

According to the findings, the gap between illegal and legal product prices has closed significantly since 2019, seeing average prices per gram of cannabis flower fall from a difference of 55% to just 20% this year.

As such, the average price of a gram of cannabis flower from illicit sources was found to be $6.24 per gram, while legal prices stood at an average of $7.96.

On average, illicit flower products were priced at 78.4% of their legal counterparts, indicating that the declining prices in the legal market may have contributed to more capture of the market.

Price disparity was also dependent on the amount of cannabis being sold in a single unit, with the differential largest at the 3.5 gram package size, where illicit prices were 67.8% of their legal alternative.

Conversely, the difference was lowest at 28-gram packages, with illicit prices representing 98.1% of the average legal price.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?